Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2020 September Corona Helsinki airport deploys sniffer dogs as fast and reliable corona testers Read more
2020 September Pharma News Novel CML-treatment asciminib performs as hoped in phase III trial Read more
2020 September Viewpoints AI-driven healthcare solutions adopted faster in low- and middle-income countries Read more
2020 August Pharma News Novel treatment for sickle cell disease granted Orphan Drug designation in EU Read more
2020 August Corona Students at Liège university bring in weekly saliva sample for corona testing Read more
Top
